Optimizing Opioid Use in Pain Management: A Comprehensive Review of Clinical Benefits, Risks, and Dependence

Abstract

[EN]Highlights: What are the main findings? Opioids are essential for managing severe acute and cancer-related pain; however, their role in chronic non-cancer pain remains controversial. Concerns regarding dependence, tolerance, and misuse have intensified during the opioid crisis. This narrative review synthesizes recent evidence on opioid pharmacology, clinical applications, dependence risk factors, and the influence of genetic, psychological, and social determinants of opioid use. It highlights emerging safer therapies, opioid rotation, and multimodal strategies that combine pharmacological and nonpharmacological approaches. Health policies should promote equitable access to essential opioids while minimizing their misuse through individualized prescribing, regular patient monitoring, and the integration of non-pharmacological interventions. Reducing prescription bias and addressing disparities are critical for improving global pain care. What are the implications of the main findings? Clinicians should prioritize a patient-centered, multimodal approach to pain management, reserving opioids for clearly indicated situations and combining them with non-pharmacological therapies to reduce long-term risks and improve functional outcomes. Health systems and policymakers should implement prescribing strategies that balance access and safety, including risk stratification, regular reassessment, and efforts to reduce social and racial disparities in opioid availability and pain treatment efficacy. Effective pain management is central to anesthesia, critical care, and perioperative medicine, and opioids remain essential agents for moderate-to-severe pain despite ongoing concerns regarding their safety and misuse. This narrative review synthesizes the current knowledge on opioid mechanisms, clinical indications, safety considerations, and evolving strategies aimed at optimizing their use. Opioids exert their analgesic effects primarily through μ-, δ-, and κ-opioid receptors, which modulate central and peripheral nociceptive pathways. They maintain a well-established role in acute postoperative and cancer-related pain, whereas their use in chronic non-cancer pain remains controversial. Contemporary evidence suggests that physiological dependence and addiction are less frequent in appropriately selected and monitored patients, although the risk increases in the presence of psychological comorbidity, prior substance use, or adverse social determinants of health. Unequal access, prescribing variability, and persistent disparities further complicate global opioid management strategies. Recent advances, including partial agonists such as buprenorphine, dual-mechanism agents such as tapentadol, individualized titration, opioid rotation, and the integration of multimodal analgesia, support safer and more tailored prescribing. Non-pharmacological interventions, including behavioral and physical therapies, increasingly complement pharmacological strategies to minimize opioid exposure and improve functional outcomes. Clinicians must balance analgesic efficacy with adverse effects, such as tolerance, opioid-induced hyperalgesia, sedation, and respiratory depression, particularly in perioperative and critically ill populations. Opioids remain indispensable for selected indications but should be incorporated into a comprehensive, patient-centered, multimodal analgesic approach that prioritizes safety, ongoing reassessment, and individualized risk mitigation.